Icecure Medical Stock Today
| ICCM Stock | USD 0.83 0.04 5.06% |
Performance8 of 100
| Odds Of DistressLess than 20
|
Icecure Medical is selling at 0.83 as of the 29th of November 2024; that is 5.06 percent up since the beginning of the trading day. The stock's lowest day price was 0.78. Icecure Medical has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Icecure Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of December 2022 and ending today, the 29th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 26th of August 2021 | Category Healthcare | Classification Health Care |
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation of tumors in the human body. The company was incorporated in 2006 and is headquartered in Caesarea, Israel. Icecure Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 55.5 M outstanding shares of which 2.31 M shares are currently shorted by private and institutional investors with about 0.46 trading days to cover. More on Icecure Medical
Moving against Icecure Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Icecure Stock Highlights
| Old Name | Icecure Medical | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsIcecure Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Icecure Medical's financial leverage. It provides some insight into what part of Icecure Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Icecure Medical (ICCM) is traded on NASDAQ Exchange in USA. It is located in 7 Ha?Eshel Street, Caesarea, Israel, 3079504 and employs 71 people. Icecure Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 46.19 M. Icecure Medical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 55.5 M outstanding shares of which 2.31 M shares are currently shorted by private and institutional investors with about 0.46 trading days to cover.
Icecure Medical currently holds about 17.73 M in cash with (12.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48.
Check Icecure Medical Probability Of Bankruptcy
Ownership AllocationIcecure Medical has a total of 55.5 Million outstanding shares. Icecure Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Icecure Ownership Details
Icecure Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Citadel Advisors Llc | 2024-09-30 | 0.0 | |
| Renaissance Technologies Corp | 2024-09-30 | 0.0 | |
| Mather Group, Inc. | 2024-06-30 | 0.0 | |
| Advisor Group Holdings, Inc. | 2024-06-30 | 0.0 | |
| Hrt Financial Llc | 2024-06-30 | 0.0 | |
| Virtu Financial Llc | 2024-06-30 | 27.2 K | |
| Xtx Topco Ltd | 2024-09-30 | 26.3 K | |
| Two Sigma Investments Llc | 2024-09-30 | 18.5 K | |
| Foundations Investment Advisors, Llc | 2024-09-30 | 10 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 6.1 K | |
| Jpmorgan Chase & Co | 2024-06-30 | 6 K |
Icecure Medical Historical Income Statement
Icecure Stock Against Markets
Icecure Medical Corporate Management
| Naum Muchnik | Dev Research | Profile | |
| Eyal Shamir | CEO Director | Profile | |
| Galit Malik | Vice Service | Profile | |
| Shay Levav | VP Applications | Profile | |
| Ronen CPA | CFO COO | Profile | |
| Merav Dotan | Vice Resources | Profile | |
| Tlalit TelTzure | Vice Marketing | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share 0.071 | Quarterly Revenue Growth 0.079 | Return On Assets (0.47) | Return On Equity (0.94) |
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.